NCT07182617 (MONITAIR-OSA) is a NA clinical trial of Standard Coaching (SOC) in Obstructive Sleep Apnea (OSA), sponsored by MonitAir.

Who is sponsoring NCT07182617?

NCT07182617 is sponsored by MonitAir.

What drugs are being tested in NCT07182617?

Interventions in NCT07182617: Standard Coaching (SOC), MonitAir RPM.

What condition does NCT07182617 study?

NCT07182617 studies Obstructive Sleep Apnea (OSA).

Is NCT07182617 still recruiting?

NCT07182617 is currently completed. Last updated 19 September 2025.

Last reviewed 2025-09-19 · How we verify

NCT07182617: MONITAIR-OSA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

MonitAir Remote Patient Monitoring Versus Standard of Care for CPAP Adherence in Obstructive Sleep Apnea

Completed NA Last updated 19 September 2025

What this trial tests

NA trial testing Standard Coaching (SOC) in Obstructive Sleep Apnea (OSA) in 200 participants. Completed in 1 April 2025.

Timeline

5 February 2024

Primary endpoint
1 April 2025

1 April 2025

Quick facts

Lead sponsor	MonitAir
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	200
Start date	5 February 2024
Primary completion	1 April 2025
Estimated completion	1 April 2025
Sites	1 location across United States

Drugs / interventions tested

Standard Coaching (SOC)
MonitAir RPM

Conditions studied

Obstructive Sleep Apnea (OSA) — all drugs for Obstructive Sleep Apnea (OSA) →

Sponsor

MonitAir

Who can join

18 and older, any sex, with Obstructive Sleep Apnea (OSA). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study tested whether using the MonitAir remote patient monitoring (RPM) platform could improve adherence to continuous positive airway pressure (CPAP) therapy for patients with obstructive sleep apnea. Patients starting CPAP treatment with BetterNight were randomized to receive either standard coaching (control group) or enhanced monitoring with the MonitAir platform (intervention group). The study measured CPAP adherence at 30, 60, and 90 days, as well as patient satisfaction and other clinical outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Obstructive Sleep Apnea (OSA)

Currently open trials in the same condition.

NCT07292922 — Digital-supported Orofacial Myofunctional Therapy in OSA · NA · recruiting
NCT06983769 — CPAP vs MAD for OSA in Patients With Cognitive Impairment. A Randomized Clinical Trial · NA · recruiting
NCT07307560 — High-Flow Nasal Cannula for Preventing Hypoxia During Sedated Endoscopy in High-Risk Obstructive Sleep Apnea Patients · NA · recruiting
NCT07103941 — IOA Preventing Occlusal Changes With MAD Use · NA · recruiting
NCT07121452 — Telehealth for Sleep Apnea: Effectiveness, Implementation, and Cost in the Military Health System · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07182617 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by MonitAir
Last refreshed: 19 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07182617.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing